Despite correlations with lower proliferation rates and lower numbers of affected axillary lymph nodes, anti-TPO antibodies have not yet been proven to engage in interaction with receptors located on cancerous breast tissue (176)
Ive been injecting over 2 years and inject in my thigh
The SELECT cardiovascular outcomes trial demonstrated that semaglutide reduced the risk of major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) by 20% in patients with obesity and established cardiovascular disease
GLP-1 RAs reduce major cardiovascular events by 14% through multiple mechanisms beyond glucose control, including anti-inflammatory effects and blood pressure reduction SELECT trial proved cardiovascular benefits extend to non-diabetic patients with obesity, showing 20% MACE reduction in those without diabetes Semaglutide, liraglutide, and dulaglutide demonstrate the strongest cardiovascular protection, with proven benefits in large outcome trials These agents provide specific benefits for heart failure with preserved ejection fraction and kidney protection, reducing albuminuria by 24% Current guidelines strongly recommend GLP-1 RAs for patients with established cardiovascular disease, regardless of diabetes status or HbA1c levels The evidence positions GLP-1 receptor agonists as fundamental cardiovascular medications rather than merely diabetes drugs with heart benefits
It can also infect non-erythroid lineage cells such as kidney cells and myocardial endothelium 260,261,262
For those who have SIBO and/or IBS, these foods can exacerbate the problem by feeding overgrown gut bacteria
